ArticleOsteoarthritis and cartilage2025
CX3CR1 modulates acute disc herniation-induced pain via regulating local inflammation and spinal microglia activation.
Article in Osteoarthritis and cartilage, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveInflammation is a key driver of disc herniation, a major cause of back pain and disability. Heterogeneous macrophages infiltrated at disc hernia sites, yet their role in disease pathology and pain remains unclear. This study investigates the role of CX3CR1⁺ macrophages and microglia in local inflammation and pain using transgenic mouse models and surgically induced disc herniation model.
methodA lumbar annular puncture model was applied to three global transgenic mouse strains: CCR2
resultsDisc herniation induced peak inflammatory cell infiltration at hernia sites at 1-week post injury, reduced by 4 weeks in both CX3CR1
conclusionsThese findings indicate a mechanistic role of CX3CR1 in mediating inflammation and pain in disc herniation. Targeting CX3CR1 may disrupt the signal interactions between disc, DRG, and spinal cords.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.